Диссертация (1173295), страница 17
Текст из файла (страница 17)
Chronic inflammatory demyelinating polyneuropathy associated withmetastatic malignant melanoma of unknown primary origin. / J.A. Palma, S. MartínAlgarra. // Journal of Neurooncology. – 2009. - № 94(2). – P. 279-281.112. Pelosof, L.C. Paraneoplastic syndromes: an approach to diagnosis and treatment.
/L.C. Pelosof, D.E. Gerber. // Mayo Clinic Proceedings. – 2010. - № 85(9). – P. 838854.113. Pinkerton, M.D. Colitis-associated cancer is dependent on the interplay betweenthe hemostatic and inflammatory systems and supported by integrin alpha(M) beta(2)engagement of fibrinogen. / M.D. Pinkerton, K.E. Talmage, K.W. Kombrinck, D.P.Witte, J. S. Palumbo // Cancer Research. - 2010. - № 70. – P. 2634-2643.114. Posner, J.B.
Paraneoplastic syndromes affecting the central nervous system. / J.B.Posner, J.O. Dalmau. // Review of Medicine. - 1997. - № 48. – P. 157-166.115. Rojas-Marcos, I. Spectrum of paraneoplastic neurologic disorders in women withbreast and gynecologic cancer. / I. Rojas-Marcos, A. Rousseau, F. Keime-Guibert, R.Reñé, S. Cartalat-Carel, J.Y. Delattre, F. Graus. // Medicine (Baltimore). – 2003. - №82(3). – P. 216-223.116. Rosenfeld, M.R. Current therapies for neuromuscular manifestations ofparaneoplastic syndromes. / M.R. Rosenfeld, J.
Dalmau. // Current Neurology andNeuroscience Reports. - 2006. - № 6(1). – P. 77-84.117. Sanders, D.B. Lambert-eaton myasthenic syndrome: diagnosis and treatment. /D.B. Sanders. // Annals of New York Academy of Sciences. - 2003. - № 998. – P. 500508.118. Schiller, M.
Dermatomyositis associated with malignant melanoma-a marker ofpoor prognosis? / M. Schiller, M. Böhm, P. Hensen, H. Riemann, T.A. Luger, D.Nashan // Journal of the American Academy of Dermatology. – 2006. - №54(2). - P.221-226.119. Selva-O'Callaghan, A. Nailfold capillary microscopy in adults with inflammatorymyopathy. / A. Selva-O'Callaghan, V. Fonollosa-Pla, E. Trallero-Araguás et al. //Seminars in Arthritis and Rheumatism. – 2010. - № 39 (5). – P. 398-404.102120. Shahab, N.
Extrapulmonary small cell carcinoma of the bladder. / N. Shahab //Seminars in Oncology. – 2007. - № 34(1). – P. 15-21.121. Sharp, L. Paraneoplastic neuromuscular disorders. / L. Sharp, S. Vernino. // Muscleand nerve. – 2012. - № 46(6). – P. 841-50.122. Shu, Y.J. Clinical and prognostic significance of preoperative plasmahyperfibrinogenemia in gallbladder cancer patients following surgical resection: aretrospective and in vitro study. / Y.J. Shu, H.
Weng, R.F. Bao et al. // BMC Cancer. 2014. - №14. – P. 566 - 573.123. Smith, A.G. Acute ventilatory failure in Lambert-Eaton myasthenic syndrome andits response to 3,4-diaminopyridine. / A.G. Smith, J. Wald. // Journal of Neurology. –1996. - № 46(4). – P. 1143-1145.124. Staton, C.A. The role of fibrinogen and related fragments in tumour angiogenesisand metastasis. / C.A.
Staton, N.J. Brown, C.E. Lewis. // Expert Opinion BiologicalTherapy. – 2003. - №3. – P. 1105-1120.125. Stender, M.T. Preoperative plasma D-dimer predicts 1-year survival in colorectalcancer patients with absence of venous thromboembolism (VTE): a prospective clinicalcohort study. / M.T.
Stender, T.B. Larsen, H.T. Sorensen, O. Thorlacius-Ussing. //Journal of Thrombosis and Haemostasis. – 2012. - №10. – P. 2027-2031.126. Sutton, I.J. Anti-Yo antibodies and cerebellar degeneration in a man withadenocarcinoma of the esophagus. / I.J. Sutton, C.J. Fursdon Davis, M.M.
Esiri, S.Hughes, E.R. Amyes, A. Vincent // Annals of Neurology. – 2001. - № 49(2). – P. 253257.127. Tilstra, J.S.3rd Scalp dermatomyositis revisited./ J.S. Tilstra, N. Prevost, P.Khera, J.C. English // Archives of Dermatology. – 2009. - № 145(9). – P. 1062-1065.128. Titulaer, M.J. Lambert-Eaton myasthenic syndrome: tumor versus non tumorforms. / Titulaer M.J., Verschuuren J.J. // Annals of the New York Academy ofSciences. – 2008. - № 1132. – P.
129-134.129. Titulaer, M.J. Screening for small-cell lung cancer: a follow-up study of patientswith Lambert-Eaton myasthenic syndrome. / M.J. Titulaer, P.W. Wirtz, L.N. Willems,K.W. van Kralingen, P.A. Smitt, J.J. Verschuuren. // Journal Clinical Oncology. – 2008.- № 26(26). – P. 4276-4281.103130. Toyka, K.V. Oculomotor signs in Lambert-Eaton myasthenic syndromecoincidence with myasthenia gravis.
/ Toyka K.V., Schneider-Gold C. // Annals ofNeurology. – 2003. - № 54(1). – P. 135-136.131. Trallero-Araguás, E. Usefulness of anti-p155 autoantibody for diagnosing cancerassociated dermatomyositis: a systematic review and meta-analysis. / E. TralleroAraguás, J.A. Rodrigo-Pendás, A. Selva-O'Callaghan et al. // Arthritis andRheumatology. – 2012. - № 64(2). – P. 523-532.132. Tseng, A.
Respiratory failure in Lambert-Eaton myasthenic syndrome precipitatedby calcium-channel blockers: report of a case and literature review. / A. Tseng, G.C.Claussen, S.J. Oh. // Journal of Clinical Neuromuscular Disease. – 2002. - №4(2). – P.60-63.133. Vedeler, C.A. Management of paraneoplastic neurological syndromes: report of anEFNS Task Force. / C.A.
Vedeler, J.C. Antoine, B. Giometto, F. Graus, W. Grisold, J.Honnorat, A.E. P. Sillevis Smitt, J.J.G.M. Verschuuren, R. Voltz. // European Journal ofNeurology. – 2006. - № 13. – P. 682–690134. Vernino, S. Autoantibody profiles and neurological correlations of thymoma. / S.Vernino, V.A. Lennon. // Clinical Cancer Research. - 2004. - № 10(21). – P. 7270-7275.135. Vernino, S. Immunomodulatory treatment trial for paraneoplastic neurologicaldisorders.
/ S. Vernino, B.P. O'Neill, R.S. Marks, J.R. O'Fallon, D.W. Kimmel. //Neuro- Oncology. - 2004. - № 6(1). – P. 55-62.136. Viala, K. Neuropathy in lymphoma: a relationship between the pattern ofneuropathy, type of lymphoma and prognosis? / K. Viala, A. Behin, T. Maisonobe et al.// Journal of Neurology, Neurosurgery and Psychiatry. – 2008. - № 79. – P. 778-782.137. Li, W. Prognostic Role of Pretreatment Plasma D-Dimer in Patients with SolidTumors: a Systematic Review and Meta-Analysis. / W. Li, Y. Tang, Y.
Song et al.//Cellular Physiology and Biochemistry. - 2018. - № 45. – P. 1663-1676.138. Wang, Y. Predictive value of plasma D-dimer levels in patients with advancednon-small-cell lung cancer. / Y. Wang, Z. Wang // Onco Targets Therapy. - 2015. - №8. – P. 805-808.104139. Wirtz, P.W. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenicsyndrome and survival in small cell lung cancer.
/ P.W. Wirtz, B. Lang, F. Graus et al. //Journal of Neuroimmunology. - 2005. - № 164(1-2). – P. 161-165.140. Wirtz, P.W. Differences in clinical features between the Lambert-Eatonmyasthenic syndrome with and without cancer: an analysis of 227 published cases. /P.W. Wirtz, T.M. Smallegange, A.R. Wintzen, J.J. Verschuuren. // Clinical Neurologyand Neurosurgery. – 2002. - № 104(4). – P.
359-363.141. Yasuda, H. Diabetic neuropathy and nerve regeneration. / H. Yasuda, M. Terada,K. Maeda, S. Kogawa, M. Sanada, M. Haneda, A. Kashiwagi, R. Kikkawa. // Progressin Neurobiology. - 2003. - № 69. – P. 229–285.142. Yu, H. Paraneoplastic Evans syndrome in a patient with adenocarcinoma of thelung: A case report. / H. Yu, R.
Fu, H. Wang, H. Liu, Z. Shao. // Thoracic cancer. 2017. - № 8. – P. 57-60.143. Yu, Z. Mechanism of intravenous immune globulin therapy in antibody-mediatedautoimmune diseases. / Z. Yu, V.A. Lennon. // The New England Journal of Medicine. 1999. - № 340. – P.
227-228.105ПРИЛОЖЕНИЕСписок больных№1ФИОА-ян Т.Г.Талон1804922А-ва Н.А.11711683А-ва Т.Г.4848374А-ко В.У. 53681Пол ВозрастДиагнозЖ55Сахарный диабет 2 типа. Сенсорнаяполинейропатия.Ж64Сахарный диабет 2 типа. Сенсорнаяполинейропатия.Ж42Миастения грависЖ71Сахарный диабет 2 типа. Сенсорнаяполинейропатия.5Рак желудка. Паранеопластическаясенсорная полинейропатия.Б-ва Т.А.16157Ж636Б-ва Ж.С.801107Ж737Б-ый Ю.А.1406776М548Б-ва О.Б.611464Ж659В-ч А.В.409286М7210В-ов В.М.1087118М5811В-ва О.Н.1343314Ж6412В-на Т.Н.690604Ж5813В-ва Т.Н.608090Ж5114В-ва Л.С.76051Ж60Идиопатический дерматомиозит15Г-ва Е.К.16060Ж5616Г-на Н.П.559400Ж66Сахарный диабет 2 типа. Сенсорнаяполинейропатия.Рак кишечника.Паранеопластическая сенсорнаяполинейропатия.Сахарный диабет 2 типа.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
